UK Markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.05-0.91 (-1.86%)
At close: 04:00PM EDT
48.05 0.00 (0.00%)
After hours: 04:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3128.29
52-week low 327.65
50-day moving average 351.91
200-day moving average 359.97

Share statistics

Avg vol (3-month) 3927.05k
Avg vol (10-day) 3853.48k
Shares outstanding 5101.66M
Implied shares outstanding 6N/A
Float 891.34M
% held by insiders 14.72%
% held by institutions 192.83%
Shares short (14 Jul 2022) 43.91M
Short ratio (14 Jul 2022) 43.37
Short % of float (14 Jul 2022) 45.19%
Short % of shares outstanding (14 Jul 2022) 43.83%
Shares short (prior month 14 Jun 2022) 44.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -107.20%
Operating margin (ttm)-107.90%

Management effectiveness

Return on assets (ttm)-11.78%
Return on equity (ttm)-55.66%

Income statement

Revenue (ttm)391.09M
Revenue per share (ttm)3.85
Quarterly revenue growth (yoy)22.20%
Gross profit (ttm)250.74M
EBITDA -397.52M
Net income avi to common (ttm)-419.24M
Diluted EPS (ttm)-2.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)962.27M
Total cash per share (mrq)9.44
Total debt (mrq)1.38B
Total debt/equity (mrq)258.40
Current ratio (mrq)4.87
Book value per share (mrq)12.96

Cash flow statement

Operating cash flow (ttm)-221.34M
Levered free cash flow (ttm)-139.88M